You are here

  • Home
  • Archive
  • Volume 1, Issue 3
  • NICE guidance for anti-tumour necrosis factor therapy in Crohn's disease: what does it mean for the inflammatory bowel disease community?

Article Text

Article menu
Download PDFPDF
Clinical quality
NICE guidance for anti-tumour necrosis factor therapy in Crohn's disease: what does it mean for the inflammatory bowel disease community?

https://doi.org/10.1136/fg.2010.001545

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; not externally peer reviewed.